Old Web
English
Sign In
Acemap
>
authorDetail
>
Marcus Liebermann
Marcus Liebermann
Goethe University Frankfurt
Biology
Cancer research
Kinase
Protein kinase B
PI3K/AKT/mTOR pathway
4
Papers
59
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The phosphatase UBASH3B/Sts-1 is a negative regulator of Bcr-Abl kinase activity and leukemogenesis
2019
Leukemia
Afsar Ali Mian
Ines Baumann
Marcus Liebermann
Florian Grebien
Giulio Superti-Furga
Martin Ruthardt
Oliver G. Ottmann
Oliver Hantschel
Show All
Source
Cite
Save
Citations (9)
Differential Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway in Acute Lymphoblastic Leukemia
2013
PLOS ONE
Susanne Badura
Tamara Tesanovic
Heike Pfeifer
Sylvia Wystub
Bart A. Nijmeijer
Marcus Liebermann
J.H. Frederik Falkenburg
Martin Ruthardt
Oliver G. Ottmann
Show All
Source
Cite
Save
Citations (49)
The Protein Tyrosine Phosphatase STS-1 Interacts with Bcr-Abl and Impairs the Response of Philadelphia-Positive Acute Lymphoblastic Leukemia (ALL) to Tyrosine Kinase Inhibitors
2010
Blood
Marcus Liebermann
Daniela Hoeller
Susanne Badura
Tamara Tesanovic
Hubert Serve
Martin Ruthardt
Oliver G. Ottmann
Show All
Source
Cite
Save
Citations (0)
1